The Historical Evolution of PEGylation: From Early Concepts to Clinical Validation to Advanced Platform for Biopharmaceuticals
PEGylation, the covalent attachment of polyethylene glycol (PEG) chains to therapeutic molecules, has evolved from a laboratory innovation in the 1970s into a mature, commercially validated technology essential to modern biopharmaceuticals. Its development reflects progressive improvements in polymer chemistry, conjugation techniques, and manufacturing scale-up.